Drug Shortage Report for RAN-LISINOPRIL

Last updated on 2021-05-01 History
Report ID 129527
Drug Identification Number 02294257
Brand name RAN-LISINOPRIL
Common or Proper name LISINOPRIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status DORMANT
Active Ingredient(s) LISINOPRIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-01
Estimated end date 2021-09-30
Actual end date 2021-04-01
Shortage status Resolved
Updated date 2021-05-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2021-05-01 French Compare
v12 2021-05-01 English Compare
v11 2021-01-31 French Compare
v10 2021-01-31 English Compare
v9 2021-01-31 French Compare
v8 2021-01-31 English Compare
v7 2020-12-03 English Compare
v6 2020-12-03 French Compare
v5 2020-12-03 English Compare
v4 2020-12-03 English Compare
v3 2020-12-03 English Compare
v2 2020-12-03 English Compare
v1 2020-12-03 English Compare

Showing 1 to 13 of 13